{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:15:03Z","timestamp":1788880503731,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["1825510000502-9"],"award-info":[{"award-number":["1825510000502-9"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301546\/2019-3"],"award-info":[{"award-number":["301546\/2019-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["400816\/2016-4"],"award-info":[{"award-number":["400816\/2016-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.biopha.2020.110497","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T05:39:11Z","timestamp":1602049151000},"page":"110497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Unmetabolized quetiapine exerts an in vitro effect on innate immune cells by modulating inflammatory response and neutrophil extracellular trap formation"],"prefix":"10.1016","volume":"131","author":[{"given":"B\u00e1rbara Osmarin","family":"Turra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Barbisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f4nica Farina","family":"Azzolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cibele Ferreira","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamara","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Elisabete","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Augusto","family":"de Oliveira Nerys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9412-7931","authenticated-orcid":false,"given":"Vitor Braga","family":"Rissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrei","family":"de Oliveira Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Elias","family":"Assmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo Em\u00edlio","family":"da Cruz Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana Pinheiro Santos","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3008-6899","authenticated-orcid":false,"given":"Ivana Beatrice M\u00e2nica","family":"da Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110497_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042746","article-title":"Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation","volume":"7","author":"Mei","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110497_bib0010","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/cns.12154","article-title":"Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair","volume":"19","author":"Zhornitsky","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2020.110497_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/ajag.12347","article-title":"Quetiapine adverse events in older adults in Australia","volume":"35","author":"El\u2010Saifi","year":"2016","journal-title":"Australasian J. Ageing"},{"key":"10.1016\/j.biopha.2020.110497_bib0020","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/TA.0000000000002011","article-title":"Quetiapine protects the blood-brain barrier in traumatic brain injury","volume":"85","author":"Robinson","year":"2018","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.biopha.2020.110497_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-018-0899-6","article-title":"Advances in pharmacotherapy of late-life depression","volume":"20","author":"Beyer","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.biopha.2020.110497_bib0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.parkreldis.2019.11.009","article-title":"Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"69","author":"Horn","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.biopha.2020.110497_bib0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/NMD.0000000000001101","article-title":"Evaluation of the clinical features, management, and prognoses of patients with Charles Bonnet syndrome","volume":"207","author":"Buyukgol","year":"2019","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.biopha.2020.110497_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11940-019-0572-3","article-title":"Treatment options for agitation in dementia","volume":"21","author":"Ringman","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.biopha.2020.110497_bib0045","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s00415-019-09200-8","article-title":"Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis","volume":"266","author":"Jin","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.biopha.2020.110497_bib0050","first-page":"1","article-title":"The psychopharmacology algorithm project at the Harvard South Shore Program: an update on bipolar depression","author":"Wang","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.biopha.2020.110497_bib0055","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40264-017-0543-0","article-title":"Second-generation antipsychotics and metabolic side effects: a systematic review of population-based studies","volume":"40","author":"Hirsch","year":"2017","journal-title":"Drug Saf."},{"key":"10.1016\/j.biopha.2020.110497_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000005900","article-title":"Development of diabetes mellitus associated with quetiapine: a case series","volume":"96","author":"Nanasawa","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2020.110497_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-017-4763-x","article-title":"Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-na\u00efve patients with a first-episode of non-affective psychosis","volume":"235","author":"V\u00e1zquez-Bourgon","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2020.110497_bib0070","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jaac.2019.01.015","volume":"58","author":"Jensen","year":"2019","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110497_bib0075","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14740338.2019.1637416","article-title":"Safety considerations in the psychopharmacology of pediatric bipolar disorder","volume":"18","author":"Sun","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.biopha.2020.110497_bib0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.24869\/psyd.2017.121","article-title":"Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature","volume":"29","author":"Vuk","year":"2017","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.biopha.2020.110497_bib0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/IJPSYM.IJPSYM_125_17","article-title":"Quetiapine-induced diabetic ketoacidosis","volume":"40","author":"Das","year":"2018","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.biopha.2020.110497_bib0090","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-019-0213-9","article-title":"Targeting innate immune mediators in type 1 and type 2 diabetes","volume":"19","author":"Donath","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2020.110497_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-019-1143-4","article-title":"The interconnection between immuno-metabolism, diabetes, and CKD","volume":"19","author":"Bonacina","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.biopha.2020.110497_bib0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0447.2001.00429.x","article-title":"Agranulocytosis and granulocytopenia associated with quetiapine","volume":"104","author":"Ruh\u00e9","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.biopha.2020.110497_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.ajp.158.4.651","article-title":"Granulocytopenia with clozapine and quetiapine","volume":"158","author":"Diaz","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110497_bib0110","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1176\/appi.psy.48.6.530","article-title":"Quetiapine-induced leucopenia and thrombocytopenia","volume":"48","author":"Shankar","year":"2007","journal-title":"Psychosomatics"},{"key":"10.1016\/j.biopha.2020.110497_bib0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pnpbp.2006.07.003","article-title":"Leukopenia and neutropenia induced by quetiapine","volume":"31","author":"Cowan","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110497_bib0120","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1345\/aph.1L617","article-title":"Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents","volume":"43","author":"Rahman","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.biopha.2020.110497_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00048674.2010.524624","article-title":"Neutropenia associated with quetiapine, olanzapine, and aripiprazole","volume":"45","author":"Lander","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110497_bib0130","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2146\/ajhp110195","article-title":"Fatal agranulocytosis associated with psychotropic medication use","volume":"69","author":"Nazer","year":"2012","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.biopha.2020.110497_bib0135","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/tx2005635","article-title":"Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis","volume":"25","author":"Li","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.biopha.2020.110497_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-015-0495-9","article-title":"Quetiapine-associated leucopenia and thrombocytopenia: a case report","volume":"15","author":"Fan","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.biopha.2020.110497_bib0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/eip.12134","article-title":"Quetiapine XR-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? A case report","volume":"9","author":"Cr\u00e9peau-Gendron","year":"2015","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.biopha.2020.110497_bib0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.apmr.2015.09.004","article-title":"Incidence of neutropenia with valproate and quetiapine combination treatment in subjects with acquired brain injuries","volume":"97","author":"Park","year":"2016","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.biopha.2020.110497_bib0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/pcn.12466","article-title":"Leukocytopenia in patients treated with multiple antipsychotics, including aripiprazole and quetiapine","volume":"71","author":"Tomita","year":"2017","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.biopha.2020.110497_bib0160","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/JCP.0000000000000752","article-title":"Fatal agranulocytosis associated with quetiapine in monotherapy: a case report","volume":"37","author":"Glocker","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2020.110497_bib0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1124\/dmd.108.023291","article-title":"Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome B5","volume":"37","author":"Bakken","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2020.110497_bib0170","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1124\/dmd.112.045237","article-title":"Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro","volume":"40","author":"Bakken","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2020.110497_bib0175","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","article-title":"Clinical pharmacokinetics of quetiapine: an atypical antipsychotic","volume":"40","author":"Devane","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2020.110497_bib0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/a-0869-8053","article-title":"Pathological Concentration of C-reactive protein is correlated to increased concentrations of quetiapine, but not of risperidone, olanzapine and aripiprazole in a naturalistic setting","volume":"53","author":"Scherf-Clavel","year":"2020","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopha.2020.110497_bib0185","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.biopha.2020.110497_bib0190","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/cdd.2009.96","article-title":"Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps","volume":"16","author":"Yousefi","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2020.110497_bib0195","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2020.110497_bib0200","series-title":"The American Psychiatric Publishing Textbook of Psychopharmacology","author":"Schatzberg","year":"2009"},{"key":"10.1016\/j.biopha.2020.110497_bib0205","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/rej.2016.1892","article-title":"The in vitro influence of a genetic superoxide-hydrogen peroxide imbalance on immunosenescence","volume":"20","author":"Barbisan","year":"2017","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.biopha.2020.110497_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cyto.2017.10.017","article-title":"Ziprasidone, a second-generation antipsychotic drug, triggers a macrophage inflammatory response in vitro","volume":"106","author":"Duarte","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2020.110497_bib0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1371\/journal.pone.0209223","article-title":"Lithium is able to minimize olanzapine oxidative-inflammatory induction on macrophage cells","volume":"14","author":"Fernandes","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110497_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0107299","article-title":"Methotrexate \u2013 related response on human peripheral blood mononuclear cells may be modulated by the Ala16Val-SOD2 gene polymorphism","volume":"9","author":"Barbisan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110497_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2019.110809","article-title":"Caffeinated beverages contribute to a more efficient inflammatory response: evidence from human and earthworm immune cells","volume":"134","author":"Alves","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2020.110497_bib0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tiv.2015.12.001","article-title":"Superoxide-hydrogen peroxide imbalance interferes with colorectal cancer cells viability, proliferation and oxaliplatin response","volume":"32","author":"Azzolin","year":"2016","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.biopha.2020.110497_bib0235","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.freeradbiomed.2009.12.005","article-title":"Modulation of redox status and calcium handling by extremely low frequency electromagnetic fields in C2C12 muscle cells: a real- time, single- cell approach","volume":"48","author":"Morabito","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2020.110497_bib0240","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00213-015-4079-7","article-title":"Haloperidol and Risperidone at high concentrations activate an in vitro inflammatory response of RAW 264.7 macrophage cells by induction of apoptosis and modification of cytokine levels","volume":"233","author":"Jung","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2020.110497_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-6-14","article-title":"Weight gain and psychiatric treatment: Is there a role for green tea and conjugated linoleic acid?","volume":"6","author":"Katzman","year":"2007","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2020.110497_bib0250","first-page":"87","article-title":"Neuroinflammation: Contemporary anti-inflammatory treatment approaches","volume":"19","author":"Al-amin","year":"2014","journal-title":"Neuroci\u00eancias (Riyadh)"},{"key":"10.1016\/j.biopha.2020.110497_bib0255","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S2215-0366(15)00310-7","article-title":"Genetic vulnerability in antipsychotic drug-induced diabetes","volume":"2","author":"Hasnain","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopha.2020.110497_bib0260","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00213-015-3976-0","article-title":"Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels","volume":"233","author":"Hefner","year":"2016","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.biopha.2020.110497_bib0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpsychires.2018.11.008","article-title":"Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis","volume":"109","author":"Mantere","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.biopha.2020.110497_bib0270","first-page":"1","article-title":"Quetiapine attenuates the neuroinflammation and executive function deficit in streptozotocin-induced diabetic mice","volume":"2019","author":"Wang","year":"2019","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.biopha.2020.110497_bib0275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pbb.2015.05.021","article-title":"The effect of the antipsychotic drug quetiapine and its metabolite norquetiapine on acute inflammation, memory and anhedonia","volume":"135","author":"Jaehne","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2020.110497_bib0280","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00011-018-1176-1","article-title":"Quetiapine ameliorates collagen-induced arthritis in mice via the suppression of the AKT and ERK signaling pathways","volume":"67","author":"Pan","year":"2018","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.biopha.2020.110497_bib0285","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00406-017-0847-1","article-title":"FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort","volume":"286","author":"Fond","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.biopha.2020.110497_bib0290","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/tx2005635","article-title":"Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis","volume":"25","author":"Li","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.biopha.2020.110497_bib0295","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.toxlet.2019.06.005","article-title":"Quetiapine induces myocardial necroptotic cell death through bidirectional regulation of cannabinoid receptors","volume":"313","author":"Li","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2020.110497_bib0300","first-page":"220","article-title":"Neutrophil biology: an update","volume":"14","author":"Kobayashi","year":"2015","journal-title":"EXCLI J."},{"key":"10.1016\/j.biopha.2020.110497_bib0305","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2020.110497_bib0310","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2337\/db15-0863","article-title":"Avogaro, NETosis delays diabetic wound healing in mice and humans","volume":"65","author":"Fadini","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2020.110497_bib0315","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.40372","article-title":"Brief report: drugs implicated in systemic autoimmunity modulate neutrophil extracellular trap formation","volume":"70","author":"Irizarry-Caro","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.biopha.2020.110497_bib0320","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/15748863113089990039","article-title":"Hyperammonemia induced by interaction of valproate and quetiapine","volume":"8","author":"Halaby","year":"2013","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.biopha.2020.110497_bib0325","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12024-012-9404-4","article-title":"The toxicology and comorbidities of fatal cases involving quetiapine","volume":"9","author":"Pilgrim","year":"2013","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.biopha.2020.110497_bib0330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajp.2017.02.003","article-title":"Neutropenia associated with quetiapine and sertraline: a case report and review of literature","volume":"26","author":"Somani","year":"2017","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.biopha.2020.110497_bib0335","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/ADM.0000000000000020","article-title":"Evaluation of quetiapine abuse and misuse reported to poison centers","volume":"8","author":"Klein-Schwartz","year":"2014","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.biopha.2020.110497_bib0340","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1574886313666180807094654","article-title":"Safety of a clozapine trial following quetiapine-induced leukopenia: a case report","volume":"14","author":"Almaghrebi","year":"2019","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.biopha.2020.110497_bib0345","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12024-018-0049-9","article-title":"Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction","volume":"15","author":"Hughes","year":"2019","journal-title":"Forensic Sci. Med. Pathol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220306909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220306909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:44:24Z","timestamp":1766083464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220306909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":69,"alternative-id":["S0753332220306909"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110497","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmetabolized quetiapine exerts an in vitro effect on innate immune cells by modulating inflammatory response and neutrophil extracellular trap formation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110497"}}